825 related articles for article (PubMed ID: 16310884)
1. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
2. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery methods for posterior segment disease.
Hsu J
Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
[TBL] [Abstract][Full Text] [Related]
4. New techniques for drug delivery to the posterior eye segment.
Eljarrat-Binstock E; Pe'er J; Domb AJ
Pharm Res; 2010 Apr; 27(4):530-43. PubMed ID: 20155388
[TBL] [Abstract][Full Text] [Related]
5. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
7. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
8. Sustained transscleral drug delivery.
Barocas VH; Balachandran RK
Expert Opin Drug Deliv; 2008 Jan; 5(1):1-10. PubMed ID: 18095925
[TBL] [Abstract][Full Text] [Related]
9. Medical devices for the treatment of eye diseases.
Yasukawa T; Ogura Y
Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
[TBL] [Abstract][Full Text] [Related]
10. Novel drug delivery systems for retinal diseases. A review.
Lee SS; Robinson MR
Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
[TBL] [Abstract][Full Text] [Related]
11. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
12. Intraocular sustained drug delivery using implantable polymeric devices.
Yasukawa T; Ogura Y; Sakurai E; Tabata Y; Kimura H
Adv Drug Deliv Rev; 2005 Dec; 57(14):2033-46. PubMed ID: 16263193
[TBL] [Abstract][Full Text] [Related]
13. [Progress in sustained-release drug delivery system for treatment of posterior segment eye diseases].
Sun SM; Cheng LY
Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):847-50. PubMed ID: 24330936
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis assessment of drug delivery systems for vitreoretinal targets.
Duvvuri S; Rittenhouse KD; Mitra AK
Adv Drug Deliv Rev; 2005 Dec; 57(14):2080-91. PubMed ID: 16271800
[TBL] [Abstract][Full Text] [Related]
15. Iontophoresis: a non-invasive ocular drug delivery.
Eljarrat-Binstock E; Domb AJ
J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
[TBL] [Abstract][Full Text] [Related]
16. Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
Loftsson T; Sigurdsson HH; Konrádsdóttir F; Gísladóttir S; Jansook P; Stefánsson E
Pharmazie; 2008 Mar; 63(3):171-9. PubMed ID: 18444504
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery strategies for combination ophthalmic treatments.
Kuppermann BD
Retina; 2009 Jun; 29(6 Suppl):S24-6. PubMed ID: 19553793
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-mediated transscleral delivery of macromolecules to the posterior segment of rabbit eye in vivo.
Suen WL; Wong HS; Yu Y; Lau LC; Lo AC; Chau Y
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4358-65. PubMed ID: 23722390
[TBL] [Abstract][Full Text] [Related]
19. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
20. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
